From just 1,200 cases spread out over 18 months, Taiwan now tops 10,000. Though low compared to other parts of East Asia, it has been a major confidence blow as Taiwan has been hailed globally for its successful strategy in keeping COVID-19 at bay.

In a watershed moment for the field, the U.S. Food and Drug Administration yesterday approved the first Alzheimer’s treatment that tackles the underlying disease pathology.

The first drug to treat Alzheimer’s disease in 18 years, which was extensively researched at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, has won approval from the Food and Drug Administration.

Progressives are livid at Sen. Joe Manchin, D-W.V. — once again.

Danica Hays is helping build the teacher of tomorrow at UNLV, and she’s not bashful in saying it’s a community effort.

SpaceX launched thousands of tiny sea creatures to the International Space Station on Thursday, along with a plaque-fighting toothpaste experiment and powerful solar panels.

The nation’s first big convention since the onset of the coronavirus pandemic kicked off this week in Las Vegas. Tourism experts hope the World of Concrete event will spur the city’s casino-based economy.

Governor Steve Sisolak has signed Assembly Bill 88 which specifically prohibits using “a name, logo, mascot, song or other identifier associated with the Confederate States of America or a federally recognized Indian tribe,” unless a tribe has specifically granted a school permission to do so.

The Food and Drug Administration (FDA) approved Biogen's aducanumab on June 7, making it the first Alzheimer's medication available in nearly 20 years and the only one that could slow the progression of the disease.